|
Humira approved to treat Crohn's disease
The UPI reports that the U.S. Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active Crohn's disease.
The FDA described Crohn's disease as a chronic, incurable, inflammatory bowel disease that causes diarrhea, cramping and abdominal pain and in some cases, abnormal connections (fistulas) leading from the intestine to the skin. It affects an estimated 1 million Americans.
|
| Advertisers |
Located in Huntingdon, TN
|
|
